Login
| TI Ref No : | 517041201 |
|---|---|
| Description : | Direct Adjustment For B770- Bevacizumab [25 Mg/ml; 100 Mg/ 4 Ml; Conc To Sol For Perfusion; Frs] Patients Under Treatment, B771- Bevacizumab [25 Mg/ml; 400 Mg/ 16 Ml; Conc To Sol P/perfusion ... contract Date: : 15-04-2025 contract Price: 67.500,00 € dead |
| Date : | 2025-04-18 |
| Deadline : | 2025-07-15 |
| Document Type : | Contracts |
